INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

Novel Marine Phenazines as Potential Cancer Chemopreventive and Anti-Inflammatory Agents

Show full item record

Bookmark or cite this item:

Files in this item

File Description Format
PDF marinedrugs-10-00451-v2.pdf (412KB) (no description provided) PDF
Title: Novel Marine Phenazines as Potential Cancer Chemopreventive and Anti-Inflammatory Agents
Author(s): Kondratyuk, Tamara P.; Park, Eun-Jung; Yu, Rui; van Breemen, Richard B.; Asolkar, Ratnakar N.; Murphy, Brian T.; Fenical, William; Pezzuto, John M.
Subject(s): apoptosis chemoprevention inflammation NFκB phenazines lavanducyanin
Abstract: Two new (1 and 2) and one known phenazine derivative (lavanducyanin, 3) were isolated and identified from the fermentation broth of a marine-derived Streptomyces sp. (strain CNS284). In mammalian cell culture studies, compounds 1, 2 and 3 inhibited TNF-α-induced NFκB activity (IC50 values of 4.1, 24.2, and 16.3 μM, respectively) and LPS-induced nitric oxide production (IC50 values of >48.6, 15.1, and 8.0 μM, respectively). PGE2 production was blocked with greater efficacy (IC50 values of 7.5, 0.89, and 0.63 μM, respectively), possibly due to inhibition of cyclooxygenases in addition to the expression of COX-2. Treatment of cultured HL-60 cells led to dose-dependent accumulation in the subG1 compartment of the cell cycle, as a result of apoptosis. These data provide greater insight on the biological potential of phenazine derivatives, and some guidance on how various substituents may alter potential anti-inflammatory and anti-cancer effects.
Issue Date: 2012-02
Publisher: MDPI
Citation Info: Kondratyuk, T. P., E. J. Park, et al. (2012). "Novel Marine Phenazines as Potential Cancer Chemopreventive and Anti-Inflammatory Agents." Marine Drugs 10(2): 451-464. DOI: 10.3390/md10020451
Type: Article
Description: The original version is available through Marine Drugs at DOI: 10.3390/md10020451 © 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license ( DOI: 10.3390/md10020451
ISSN: 1660-3397
Sponsor: This work was supported by program project grant P01 CA48112 (to JP) and CA44848 (to WF) awarded by the National Cancer Institute.
Date Available in INDIGO: 2012-09-10

This item appears in the following Collection(s)

Show full item record


Country Code Views
United States of America 134
China 34
United Kingdom 12
Germany 5
Russian Federation 3


My Account


Access Key